Tower Research Capital LLC (Trc) Tg Therapeutics, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 32,498 shares of TGTX stock, worth $977,864. This represents 0.02% of its overall portfolio holdings.
Number of Shares
32,498
Previous 3,132
937.61%
Holding current value
$977,864
Previous $73,000
1239.73%
% of portfolio
0.02%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding TGTX
# of Institutions
372Shares Held
85.5MCall Options Held
3.78MPut Options Held
3M-
Vanguard Group Inc Valley Forge, PA15.6MShares$469 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$343 Million0.0% of portfolio
-
State Street Corp Boston, MA9.2MShares$277 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.19MShares$96.1 Million0.01% of portfolio
-
Pictet Asset Management Holding Sa Carouge, V82.79MShares$84.1 Million0.09% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $4.37B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...